Evidence map›Paper›PMID 41436642›Full record

ArticleEuropean radiology2026

MRI scoring of pleural findings in cystic fibrosis does not require intravenous contrast media.

Isabel T Schobert, Helena Posch, Ingo G Steffen, Eva Steinke, Jobst Roehmel, Marcus A Mall, Mirjam Stahl, Felix Doellinger

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Isabel T Schobert *Department of Radiology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Helena Posch *Department of Radiology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Ingo G SteffenDepartment of Pediatric Hematology and Oncology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Eva SteinkeDepartment of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Jobst RoehmelDepartment of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Marcus A MallDepartment of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Mirjam StahlDepartment of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Felix DoellingerDepartment of Radiology, Charité-Universitätsmedizin Berlin, Berlin, Germany. f.doellinger@uke.de.ORCID http://orcid.org/0000-0003-3661-8569

Funding

Bundesministerium für Bildung und Forschung 01GL2401ABundesministerium für Bildung und Forschung 82DZL009B1
6 · The paper itself

Abstract

objectivesCystic fibrosis (CF) leads to severe lung disease requiring regular monitoring. The morpho-functional chest MRI score enables reproducible semi-quantitative assessment of CF-related pulmonary and pleural changes, but the optimal sequences for pleural evaluation and the need for intravenous contrast media remain uncertain. This study aims to investigate the usability and agreement of different unenhanced and contrast-enhanced MRI sequences in assessing CF-related pleural findings using a blinded multi-reader study design. MATERIALS AND

methodsThis study included 75 people with CF (pwCF), who underwent morpho-functional chest MRI comprising contrast-enhanced and unenhanced sequences. Three 3D gradient echo T1-weighted sequences (unenhanced with (T1UEFS) and without fat saturation (T1UE), contrast-enhanced with fat saturation (T1CEFS)) and a high-resolution T2-weighted sequence with fat saturation (T2FS) were evaluated by two blinded independent readers applying the chest MRI scoring system for each individual lung lobe and the entire pleura (lobar/total pleural findings score). In case of deviations, a thoracic radiologist adjudicated. Statistical analyses included Spearman's correlation, Kruskal-Wallis test, and intraclass correlation coefficients.

resultsInterreader agreement was consistently good for all sequences and for all pulmonary lobes. While all unenhanced MRI sequences showed strong correlation with T1CEFS regarding the total pleural findings score, T1UEFS showed the highest agreement. T2FS tended to overestimate, and T1UE tended to underestimate lobar and total pleural findings scores.

conclusionsContrast-enhanced T1-weighted imaging is standard for assessing CF-related pleural inflammation and thickening. Our findings show that contrast agent-free fat-saturated T1-weighted sequences provide equivalent diagnostic value, indicating contrast media are not required for pleural assessment in pwCF. KEY POINTS: Question It is unclear which MRI sequence is best for assessing signs of pleurisy in pwCF and whether intravenous contrast media is required. Findings Pleural inflammation and thickening can be diagnosed just as precisely with an unenhanced fat-saturated T1-weighted sequence as with a contrast-enhanced T1-weighted sequence. Clinical relevance The assessment of pleural findings in MRI is not dependent on the use of intravenous contrast media. For pwCF, this paves the way for future routine MRI monitoring without contrast agents, thereby streamlining imaging protocols and reducing patient burden.

Indexed as

Contrast MediaCystic FibrosisMagnetic Resonance ImagingPleuraPleural DiseasesAdolescentAdultFemaleHumansMaleMiddle AgedReproducibility of ResultsYoung AdultContrast MediaContrast mediaCystic fibrosisMagnetic resonance imagingPleura

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.